|
|
||||||||
American Journal of Clinical Nutrition, Vol 56, 158-163, Copyright © 1992 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
SE Chin, RW Shepherd, BJ Thomas, GJ Cleghorn, MK Patrick, JA Wilcox, TH Ong, SV Lynch and R Strong
Queensland Liver Transplant Service, Royal Children's Hospital, Brisbane, Australia.
Malnutrition is common in children with end-stage liver disease (ESLD) awaiting orthotopic liver transplantation (OLT), and nutritional support is assuming an important role in preoperative management. To evaluate preoperative nutritional therapy, 19 children (median age 1.25 y) with ESLD awaiting OLT were prospectively studied. Two high-energy, isoenergetic and isonitrogenous nutritional formulations delivered nasogastrically were compared: a branched-chain amino acid (BCAA)- enriched semielemental formulation and a matched standard semielemental formation. Twelve of 19 patients completed a randomized controlled study before OLT and 10 of 19 completed a full crossover study. Improvements in weight and height occurred during the BCAA supplements, with no statistical change on the standard formulation. Significant increases in total body potassium, midupper arm circumference, and subscapular skinfold thickness occurred during the BCAA supplements, whereas no significant changes occurred during the standard formulation period. Significantly fewer albumin infusions were required during the BCAA supplement. These findings suggest that BCAA-enriched formulas have advantages over standard semielemental formulas in improving nutritional status in children with ESLD, and are deserving of wider application and study.
This article has been cited by other articles:
![]() |
D. R. Mager, L. J. Wykes, E. A. Roberts, R. O. Ball, and P. B. Pencharz Mild-to-Moderate Chronic Cholestatic Liver Disease Increases Leucine Oxidation in Children J. Nutr., April 1, 2006; 136(4): 965 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Mager, L. J. Wykes, E. A. Roberts, R. O. Ball, and P. B. Pencharz Branched-Chain Amino Acid Needs in Children with Mild-to-Moderate Chronic Cholestatic Liver Disease J. Nutr., January 1, 2006; 136(1): 133 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Marchesini, R. Marzocchi, M. Noia, and G. Bianchi Branched-Chain Amino Acid Supplementation in Patients with Liver Diseases J. Nutr., June 1, 2005; 135(6): 1596S - 1601S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Wallace, W. J. Abbott-Johnson, D. H. G. Crawford, R. Barnard, J. M. Potter, and R. C. Cuneo GH Treatment in Adults with Chronic Liver Disease: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2751 - 2759. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |